Search Results - "Gener-Ricos, Georgina"

TP53 Y220C mutations in patients with myeloid malignancies.

Authors: Gener-Ricos, Georgina Bewersdorf, Jan P. Loghavi, Sanam et al.

Source: Leukemia & Lymphoma. Oct2024, Vol. 65 Issue 10, p1511-1515. 5p.

Advances in the management of higher-risk myelodysplastic syndromes: future prospects.

Authors: Gener-Ricos, Georgina Rodriguez-Sevilla, Juan Jose Urrutia, Samuel et al.

Source: Leukemia & Lymphoma. Sep2024, Vol. 65 Issue 9, p1233-1244. 12p.

Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia.

Authors: Azevedo, Roberta S. Braish, Julie Gener-Ricos, Georgina et al.

Source: Leukemia & Lymphoma. Jan2026, Vol. 67 Issue 1, p220-224. 5p.

NPM1‐mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage.

Authors: Gener‐Ricos, Georgina Bataller, Alex Rodriguez‐Sevilla, Juan Jose et al.

Source: Cancer (0008543X). Oct2024, Vol. 130 Issue 20, p3452-3462. 11p.

Outcomes of patients with therapy‐related myeloid neoplasms after treatment with poly(ADP‐ribose) polymerase proteins inhibitors for solid tumours.

Authors: Almanza‐Huante, Emmanuel Bataller, Alex Urrutia, Samuel et al.

Source: British Journal of Haematology. May2023, Vol. 201 Issue 3, pe25-e29. 5p.

PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia.

Authors: Bataller, Alex Chien, Kelly S. Sasaki, Koji et al.

Source: Leukemia Research. Apr2023, Vol. 127, pN.PAG-N.PAG. 1p.

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Authors: Bazinet A Bataller A Chien K et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Mar 27; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 27.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results.

Authors: Gener-Ricos G Haddad FG Sasaki K et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Oct; Vol. 23 (10), pp. 742-748. Date of Electronic Publication: 2023 May 23.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm.

Authors: Bataller A Gener-Ricos G Almanza-Huante E et al.

Source: Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2695-2706.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Germline Predisposition to Myelodysplastic Syndromes.

Authors: Gener-Ricos G Gerstein YS Hammond D et al.

Source: Cancer journal (Sudbury, Mass.) [Cancer J] 2023 May-Jun 01; Vol. 29 (3), pp. 143-151.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100931981 Publication Model: Print Cited Medium: Internet ISSN: 1540-336X (Electronic) Linking ISSN: 15289117 NLM ISO Abbreviation: Cancer J Subsets: MEDLINE